Navigation Links
BioNano Genomics Announces One Human : One Chip : One Day

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- BioNano Genomics announced today achievement of a major milestone for the Irys system: the ability to collect human data at 30X depth, sufficient for a genome map, in 24 hours on a single chip.  This new capability was established and demonstrated for the IrysChipTM V2, the high-throughput chip for the IrysTM System and will be rolled out to BioNano's collaborators and customers over the next two months. BioNano will be showcasing this advancement at the American Society for Human Genetics (ASHG) 2014 Meeting taking place October 18-22 in San Diego.  The one human : one chip : one day will provide a more rapid, accurate and comprehensive way of identifying structural variation to drive genomics discoveries.  BioNano also announced major software updates to IrysViewTM and IrysSolveTM, to improve visualization and analysis.

"We know that structural variation within and among genomes is key to understanding human diversity and disease, and the Irys System is a key step forward in providing a complete picture to uncover biologically and clinically significant human genetic variations," said Erik Holmlin, Ph.D., president and CEO of BioNano Genomics. "This advancement will dramatically increase the number of samples that can be mapped and pave the way toward true population-scale studies using the Irys system."

Structural variation can involve millions of nucleotides of heterogeneity within every genome and is implicated in a rapidly growing list of diseases and conditions.  Structural variation occurs in all genomes and includes deletions, duplications, copy-number variants, insertions, inversions, translocations and repeats. BioNano's Irys System reveals the location, order and orientation of clinically relevant genome components, including the length and location of long repeats and viral integration sites, which are often implicated in complex diseases, such as cancer.

"Irys delivers the scalability and reliability to detect and assemble all structural variations to obtain a comprehensive view of a genome and significantly advance the completion of genome assemblies," added Dr. Holmlin.  "We are continually innovating and evolving the Irys System so our collaborators and customers can accelerate their research and access the information contained within a complete genome for a deeper understanding of the role of genetic variation in human disease."

ASHG 2014 Workshop

BioNano will be presenting the latest Irys research at ASHG 2014 in a workshop, entitled, "Exploring the Dark Matter of the Genome: Uncovering the Full Impact of Structural Variation in Cancer and the Human Genome with Single-Molecule De Novo Assembly" will feature presentations by:

- Dr. Vanessa Hayes, University of Sydney and Garvan Institute
- Dr. David Jaffe, Broad Institute of MIT and Harvard
- Veronica Searles, University of Colorado Denver

The workshop will take place Monday, October 20 from 12:30 pm to 2 pm in Room 28A on the upper level of the San Diego Convention Center.   Register here.

About Irys

Irys makes it possible to routinely and accurately detect genomic structural variation and to finish genome assemblies. The fully automated Irys benchtop instrument uses the IrysChip to uncoil and confine long DNA molecules in proprietary Nanochannel Arrays™ where they are uniformly linearized in a highly parallel display for high-resolution, single-molecule imaging. Irys does not employ DNA fragmentation or amplification, which are typical with next-generation sequencing. The result is sequence information over extremely long "reads" ranging from hundreds of kilobases to a megabase, where the sample's valuable structural information is preserved. Irys makes it possible for researchers to directly observe structural variants including replications, deletions, translocations and inversions.

About BioNano Genomics

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company's platform provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by private investors and grant funding from genomics programs at federal agencies, including the NIH and NIST-ATP.

Notes: BioNano Genomics is a trademark of BioNano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.

SOURCE BioNano Genomics
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. BioNano Genomics Raises $10 Million Financing To Advance Irys System For Human Genome Analysis
2. Empire Genomics Chooses Funakoshi as Japan Distributor
3. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
4. Gentris Corporation Launches New Pharmacogenomics Services
5. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
6. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
7. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
8. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
9. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
10. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
11. Rosetta Genomics Announces Exercise and Closing of Underwriters Over-Allotment Option
Post Your Comments:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):